Categories
LEMTRADA (alemtuzumab) – Risk of Autoimmune Hepatitis, Haemophagocytic Lymphohistiocytosis, and Associated Serious Cardiovascular Reactions
LEMTRADA (alemtuzumab) – Risk of Autoimmune Hepatitis, Haemophagocytic Lymphohistiocytosis, and Associated Serious Cardiovascular Reactions
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/71299a-eng.php